Newbury Pharmaceuticals AB (publ) (NEWBRY.ST)
SEK 3.42
(-2.29%)
SEK 3.42
(-2.29%)
| Breakdown | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Total Assets | 90.87 Million | 72.91 Million | 86.9 Million | 42.8 Million |
| Total Current Assets | 43.97 Million | 27.23 Million | 36.47 Million | 15.76 Million |
| Cash And Short Term Investments | 15.3 Million | 8.52 Million | 33.33 Million | 13.14 Million |
| Cash and Cash Equivalents | 15.3 Million | 8.52 Million | 33.33 Million | 13.14 Million |
| Short Term Investments | - | - | - | - |
| Net Receivables | - | - | - | - |
| Inventory | 4.99 Million | 2.1 Million | 1.77 Million | - |
| Other Current Assets | 23.67 Million | 16.6 Million | - | 1000.00 |
| Total Non-Current Assets | 46.89 Million | 45.68 Million | 50.43 Million | 27.03 Million |
| Net PPE | - | - | - | - |
| Good Will And Intangible Assets | 46.89 Million | 45.68 Million | 50.43 Million | 27.03 Million |
| Good Will | - | 2.12 Million | 3.04 Million | 3.95 Million |
| Intangible Assets | - | 43.55 Million | 47.39 Million | 23.08 Million |
| Long-Term Investments | - | - | - | - |
| Tax Assets | - | - | - | - |
| Other Non Current Assets | - | - | - | - |
| Other Assets | - | - | - | - |
| Total Liabilities | 38.95 Million | 23.53 Million | 18.13 Million | 4.33 Million |
| Total Current Liabilities | 29.44 Million | 11.76 Million | 6.05 Million | 4.33 Million |
| Account Payables | - | 4.27 Million | 2.03 Million | 1.88 Million |
| Tax Payables | - | 157 Thousand | 176 Thousand | 69 Thousand |
| Short Term Debt | - | - | - | - |
| Deferred Revenue | - | - | - | - |
| Other Current Liabilities | 29.44 Million | 7.49 Million | 4.02 Million | 2.45 Million |
| Total Non Current Liabilities | 9.5 Million | 11.76 Million | 12.07 Million | - |
| Long-Term Debt | - | - | - | - |
| Deferred Revenue Non Current | - | - | - | - |
| Deferred Tax Liabilities Non Current | - | - | - | - |
| Other Non Current Liabilities | 9.5 Million | 11.76 Million | 12.07 Million | - |
| Other Liabilities | - | - | - | - |
| Total Equity | 51.91 Million | 49.38 Million | 68.77 Million | 38.46 Million |
| Stock Holders Equity | 51.91 Million | 49.38 Million | 68.77 Million | 38.46 Million |
| Common Stock | - | 623 Thousand | 623 Thousand | 157 Thousand |
| Retained Earnings | - | - | - | - |
| Accumulated other comprehensive income | - | - | - | - |
| Common Stock Equity | 51.91 Million | 49.38 Million | 68.77 Million | 38.46 Million |
| Capital Lease Obligation | - | - | - | - |
| Total Investments | - | - | - | - |
| Total Debt | - | - | - | - |
| Net Debt | -15.3 Million | -8.52 Million | -33.33 Million | -13.14 Million |
| Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 |
|---|---|---|---|---|---|---|
| Total Assets | 90.87 Million | 90.76 Million | 84.12 Million | 94.09 Million | 72.91 Million | 72.91 Million |
| Total Current Assets | 43.97 Million | 43.52 Million | 35.62 Million | 46.42 Million | 27.23 Million | 27.23 Million |
| Cash And Short Term Investments | 15.3 Million | 15.43 Million | 6.41 Million | 15.89 Million | 8.52 Million | 8.52 Million |
| Cash and Cash Equivalents | 15.3 Million | 15.43 Million | 6.41 Million | 15.89 Million | 8.52 Million | 8.52 Million |
| Short Term Investments | - | - | - | - | - | - |
| Net Receivables | - | - | - | - | - | - |
| Inventory | 4.99 Million | 6.34 Million | 6.45 Million | 5.4 Million | 2.1 Million | 2.1 Million |
| Other Current Assets | 23.67 Million | 21.74 Million | - | - | - | - |
| Total Non-Current Assets | 46.89 Million | 47.23 Million | 48.5 Million | 47.66 Million | 45.68 Million | 45.68 Million |
| Net PPE | - | - | - | - | - | - |
| Good Will And Intangible Assets | 46.89 Million | 47.23 Million | 48.5 Million | 47.66 Million | 45.68 Million | 45.68 Million |
| Good Will | - | - | - | - | 2.12 Million | 2.12 Million |
| Intangible Assets | - | - | - | - | 43.55 Million | 43.55 Million |
| Long-Term Investments | - | - | - | - | - | - |
| Tax Assets | - | - | - | - | - | - |
| Other Non Current Assets | - | - | - | - | - | - |
| Other Assets | - | - | - | - | - | - |
| Total Liabilities | 38.95 Million | 40.69 Million | 43.34 Million | 48.43 Million | 23.53 Million | 23.53 Million |
| Total Current Liabilities | 29.44 Million | 28.56 Million | 31.41 Million | 21.27 Million | 11.76 Million | 11.76 Million |
| Account Payables | - | - | - | - | 4.27 Million | 4.27 Million |
| Tax Payables | - | - | - | - | 157 Thousand | 157 Thousand |
| Short Term Debt | - | - | - | - | - | - |
| Deferred Revenue | - | - | - | - | - | - |
| Other Current Liabilities | 29.44 Million | 28.56 Million | - | 21.27 Million | 7.49 Million | 7.49 Million |
| Total Non Current Liabilities | 9.5 Million | 12.13 Million | 11.93 Million | 27.16 Million | 11.76 Million | 11.76 Million |
| Long-Term Debt | - | - | - | - | - | - |
| Deferred Revenue Non Current | - | - | - | - | - | - |
| Deferred Tax Liabilities Non Current | - | - | - | - | - | - |
| Other Non Current Liabilities | 9.5 Million | 12.13 Million | - | 27.16 Million | 11.76 Million | 11.76 Million |
| Other Liabilities | - | - | - | - | - | - |
| Total Equity | 51.91 Million | 50.06 Million | 40.77 Million | 45.65 Million | 49.38 Million | 49.38 Million |
| Stock Holders Equity | 51.91 Million | 50.06 Million | 40.77 Million | 45.65 Million | 49.38 Million | 49.38 Million |
| Common Stock | - | - | - | - | 623 Thousand | 623 Thousand |
| Retained Earnings | - | - | - | - | - | - |
| Accumulated other comprehensive income | - | - | - | - | - | - |
| Common Stock Equity | 51.91 Million | 50.06 Million | 40.77 Million | 45.65 Million | 49.38 Million | 49.38 Million |
| Capital Lease Obligation | - | - | - | - | - | - |
| Total Investments | - | - | - | - | - | - |
| Total Debt | - | - | - | - | - | - |
| Net Debt | -15.3 Million | -15.43 Million | -6.41 Million | -15.89 Million | -8.52 Million | -8.52 Million |
688305
VANTI
002720
JINDALSTEL
ANRGF
121600